Skip to main content
. 2004 Apr 19;2004(2):CD000967. doi: 10.1002/14651858.CD000967.pub2

Europe‐USA 1994.

Methods Allocation: randomised ‐ computer generated. 
 Blindness: double‐blind ‐ no further details. 
 Duration: 6 weeks (> 1 day washout).
Participants Diagnosis: schizophrenia (DSM‐III‐R). 
 Inclusion criteria: BPRS* >/=27, CGI >/=4. 
 N=286. 
 Age: mean ˜37 years. 
 Sex: M 203, F 83.
Interventions 1. Quetiapine: mean dose 360 mg/day. N=96. 
 2. Quetiapine: mean dose 209 mg/day. N=94. 
 3. Placebo: N=96.
Outcomes Global state: CGI. 
 Mental state: BPRS, BPRS positive, SANS, PANSS‐N. 
 Adverse effects: AIMS, Barnes Akathisia Scale, SAS, specific side‐effects list. 
 Leaving the study early.
Notes * 0‐6 scoring system.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Low risk A ‐ Adequate